Access official updates regarding Finecure’s industrial growth and regulatory achievements. This portal tracks our journey as a global generic leader, from the expansion of our 4 manufacturing plants to new therapeutic breakthroughs in our NDDS pipeline.
Validating our sustained commitment to brand trust and market leadership on a global scale.
Strengthening our Anti-Allergic segment with high-efficacy, registration-ready formulations for international markets.
Showcasing our R&D capability in high-demand chronic care molecules with complete CTD/eCTD dossier support.
Investing in the high-tier technical talent required to maintain world-class pharmaceutical standards.
